RecruitingMajor Depressive Disorder
A Study to Evaluate BMS-986511 in Adults With Major Depressive Disorder
Eligible age
18–65 yrs
Accepts
All genders
Locations
10 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
A Study to Evaluate BMS-986511 in Adults with Major Depressive Disorder
Sponsor: Bristol-Myers Squibb
You may qualify if…
- ✓ Participants must meet the MDD diagnosis per DSM-5 criteria confirmed by structured interview.
- ✓ Participant must have current moderate to severe MDE confirmed by clinical assessment and validated scale.
- ✓ Participant must have current MDE duration \>12 weeks at screening.
- ✓ Outpatient participants able to comply with study procedures.
- ✓ Participant require medication washout completed before baseline.
- ✓ Participant must have BMI within protocol range.
- ✓ Participants must meet reproductive safety requirements.
You may not qualify if…
- ✕ Participants must not have other primary psychiatric disorders or a history of treatment-resistant depression during the current episode.
- ✕ Participants must not have recent history of active suicidal ideation or attempt within the past year.
- ✕ Participants must not have prior lifetime treatment with electroconvulsive therapy, ketamine/esketamine, deep brain stimulation, or transcranial magnetic stimulation.
- ✕ Participants must not have recent history of alcohol/substance abuse or use of cannabis.
- ✕ Participants must not have significant ECG abnormalities, or poorly controlled diabetes.
- ✕ Other protocol defined inclusion/exclusion criteria apply.
Where it's recruiting
Arizona
Phoenix
Arkansas
Little Rock · Rogers
California
Garden Grove · Glendale · Lemon Grove · Oakland …
Florida
Jacksonville · Orlando
Georgia
Atlanta
Maryland
Gaithersburg
New York
Cedarhurst · Mount Kisco · Staten Island
Ohio
Columbus
Oklahoma
Oklahoma City
Washington
Everett
Source: ClinicalTrials.gov · NCT07772531 · last updated 2026-11-18